Atypical antipsychotic drugs perturb AMPK-dependent regulation of hepatic lipid metabolism. (Q53443229)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224484%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Atypical antipsychotic drugs perturb AMPK-dependent regulation of hepatic lipid metabolism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224484%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224484%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Kyoung-Jin Oh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224484%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Jae Bum Kim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224484%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

7

Heon-Jeong Lee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224484%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Jinyoung Park

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224484%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Su Yeon Lee

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224484%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Injae Hwang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224484%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Tae-Sik Park

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224484%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

11 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224484%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology - Endocrinology and Metabolism

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224484%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

300

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224484%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

E624-32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224484%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224484%20AND%20SRC:MED&resulttype=core&format=json

Kinase-independent transcriptional co-activation of peroxisome proliferator-activated receptor alpha by AMP-activated protein kinase

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Olanzapine (LY170053, 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine), but not the novel atypical antipsychotic ST2472 (9-piperazin-1-ylpyrrolo[2,1-b][1,3]benzothiazepine), chronic administration induces weight gain, hyper

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

A clinical study of the association of antipsychotics with hyperlipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Endocannabinoids and liver disease--review

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Protein sensors for membrane sterols

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

AMPK phosphorylation of raptor mediates a metabolic checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Glycerolipid biosynthesis in rat adipose tissue. Influence of adipose-cell size and site of adipose tissue on triacylglycerol formation in lean and obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Regulation of hepatic gluconeogenesis by an ER-bound transcription factor, CREBH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Metformin reverses fatty liver disease in obese, leptin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Sterol regulatory element-binding protein 1 is negatively modulated by PKA phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Central nervous system delivery of the antipsychotic olanzapine induces hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Olanzapine-induced elevation of serum triglyceride levels in a normal weight patient with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

TORC2 regulates hepatic insulin signaling via a mammalian phosphatidic acid phosphatase, LIPIN1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

The effects of antipsychotics on the density of cannabinoid receptors in the dorsal vagal complex of rats: implications for olanzapine-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Endocannabinoid signaling in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Olanzapine induces SREBP-1-related adipogenesis in 3T3-L1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Adiponectin and thiazolidinedione targets CRTC2 to regulate hepatic gluconeogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Salt-inducible kinase regulates hepatic lipogenesis by controlling SREBP-1c phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

The role of AMP-activated protein kinase in the action of ethanol in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Peroxisome Proliferator-Activated Receptors, Fatty Acid Oxidation, Steatohepatitis and Hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010

Role of AMP-activated protein kinase in mechanism of metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2010